Key result
Transesophageal echocardiography determined a possible stroke etiology in 48.4% of patients with previously cryptogenic stroke and changed secondary prevention in 16.4% of cases.
Why the study?
The indication for transesophageal echocardiography in acute stroke is unclear across different age groups with cryptogenic stroke.
Does transesophageal echocardiography improve the determination of stroke etiology and secondary prevention in patients with acute retinal or cerebral ischemia?
Observational (n=485)
No
Does transesophageal echocardiography improve the determination of stroke etiology and secondary prevention in patients with acute retinal or cerebral ischemia?
TEE is highly valuable for determining stroke etiology and influencing secondary prevention, with its diagnostic yield varying significantly by age (septal anomalies in young patients vs. complex aortic atheroma and AF indicators in older patients).
TEE may refine etiology and prevention in cryptogenic stroke; leaves open age-specific indications and outcome impact.
Introduction: The indication of transesophageal echocardiography (TEE) in acute stroke is unclear. Thus, we systematically studied the impact of TEE on determining stroke etiology and secondary prevention in patients of different age-groups with cryptogenic stroke. Methods: Four hundred and eighty five consecutive patients with acute retinal or cerebral ischemia were prospectively included and underwent routine stroke workup including TEE. Stroke etiology was identified according to the TOAST classification and patients were divided in those with determined and cryptogenic stroke etiology without TEE results. Then, the frequency of high- and potential-risk sources in TEE was evaluated in <55, 55–74, and ≥75 year-old patients with cryptogenic stroke etiology. Results: Without TEE, stroke etiology was cryptogenic in 329(67.8%) patients and TEE determined possible etiology in 158(48.4%) of them. In patients aged <55, 55–74, ≥75, TEE detected aortic arch plaques ≥4 mm thickness in 2(1.2%), 37(23.0%), and 33(40.2%) and plaques with superimposed thrombi in 0(0.0%), 5(3.1%), and 7(8.5%); left atrial appendage peak emptying flow velocity ≤30cm/s in 0(0.0%), 1(0.6%), and 2(2.4%), spontaneous echo contrast in 0(0.0%), 1(0.6%), and 6(7.3%), endocarditis in 0(0.0%), 0(0.0%), and 1(1.2%) and patent foramen ovale (PFO) plus atrial septum aneurysm (ASA) in 18(20.9%), 32(19.9%), and 14(17.1%), respectively. TEE changed secondary prevention in 16.4% of these patients following guidelines of 2010/11 and still 9.4% when applying the guidelines of 2020. Conclusions: TEE was highly valuable for determining stroke etiology and influenced individual secondary prevention based on available treatment guidelines and expert opinion in most cases. In young patients the impact of TEE was limited to the detection of septal anomalies. By contrast, in older patients TEE detected high numbers of complex aortic atheroma and potential indicators of paroxysmal atrial fibrillation.
No takes yet. Share an insight, caveat, or question.
Strecker et al. (2020) conducted an observational in Acute cerebral or retinal ischemia (stroke) (n=485). Transesophageal echocardiography (TEE) vs. Routine diagnostics alone was evaluated on Determination of possible stroke etiology in patients with cryptogenic stroke after routine diagnostics. Transesophageal echocardiography determined a possible stroke etiology in 48.4% of patients with previously cryptogenic stroke and changed secondary prevention in 16.4% of cases.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: